Eli Lilly and Co said on Tuesday Chief Financial Officer Josh Smiley had resigned after allegations about a personal relationship sparked an investigation that found "inappropriate personal communication" with some company employees.
S&P 500, Dow miss out on new records and snap 6-day win streak MarketWatch 2/9/2021
MARKET SNAPSHOT
U.S. stocks ended mostly lower on Tuesday, capping a turbulent session that saw markets swing between small gains and losses, as momentum for a record-setting market rally slowed.
Investors were focused on the potential for another round of government spending to boost the economic recovery from the coronavirus pandemic.
What did major benchmarks do?
The Dow Jones Industrial Average fell 9.93 points, or less than 0.1%, to end at 31,375.83, after setting an intraday record of 31,439.47.
The S&P 500 closed down 4.36 points, or 0.1%, at 3,911.23, after recording an all-time intraday high of 3,918.35.
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2020 Earnings Call. [Operator Instructions]
I would now like to turn the conference over to our host, Vice President of Investor Relations, Mr. Kevin Hern. Please go ahead, sir.
Kevin Hern
Vice President of Investor Relations
Good morning. Thank you for joining us for Eli Lilly and Company s Q4 2020 earnings call. I m Kevin Hern, Vice President of Investor Relations. Joining me on today s call are Dave Ricks, Lilly s Chairman and CEO; Josh Smiley, Chief Financial Officer; Dr. Dan Skovronsky, Chief Scientific Officer; Anne White, President of Lilly Oncology; Ilya Yuffa, President of Lilly Bio-Medicines; and Mike Mason, President of Lilly Diabetes. We re also joined by Sara Smith and Lauren Zierke of the Investor Relations team.